期刊文献+

远端保护装置下血管内治疗椎动脉开口狭窄 被引量:3

Treatment ostium of vertebral artery stenosis using stent assisted angioplasty under distal protective device
在线阅读 下载PDF
导出
摘要 目的评价在远端保护装置下采用血管内支架成形术治疗椎动脉开口狭窄的安全性及疗效。方法分析22例椎动脉开口狭窄患者行椎动脉开口支架成形术时应用远端保护装置,并对手术疗效及并发症进行分析。结果在远端保护装置下22例患者共置入22个支架,术后椎动脉开口造影证实,狭窄由76.0%±9.6%下降至13.9%±3.2%。技术成功率95.4%,1例因血管痉挛,放置保护装置失败。在1、3、6个月随访时按Malek评分,12例评定分为1分,10例评定分为2分。结论在保护装置下治疗椎动脉开口狭窄效果确切。 Objective To assess the feasibility,safety using stent assisted angioplasty under distal protective device for treatment on ostium of vertebral artery stenosis. Methods The operation strategy and effects were analysed retrospectively for 22 patients who using stent assisted angioplasty under distal protective device,analysis operation effect and complication. Rseults Twenty- two patients of ostium of vertebral artery stenosis using stent assisted angioplasty under distal protective device implant 22 stents,The stents of nineteen patients were correctly placed based on angiography. The mean degree of stenosis decr eased from 76.0% ±9.6% beforethe pr ocedure to 13.9% ±3.2%) after stenting,operation achievement ratio is 95. 4%,one patient was failure because angiospasm after using protective device,and in 1,3,6 month follow up,according to Malek scale,15 patients belonged to scale 1,and 7 patients belonged to scale 2. Conclusion Using protective device and stent assisted angioplasty for tr eatment on ostium of vertebral artery stenosis is safe and feasible.
出处 《脑与神经疾病杂志》 2016年第1期27-31,共5页 Journal of Brain and Nervous Diseases
关键词 远端保护装置 椎动脉开口狭窄 血管内支架成形术 Protective device Ostium of vertebral artery stenosis Stent assisted angioplasty
  • 相关文献

参考文献3

二级参考文献26

  • 1沈阳,王贵学,全学军,俞青松.NiTi合金血管内支架表面改性及其生物相容性研究[J].中国医疗器械杂志,2006,30(1):3-6. 被引量:17
  • 2Awata M,Kotani J,Uematsu M,et al.Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation:comparison with bare-metal stents.Circulation,2007,116:910-916.
  • 3Morice MC,Serruys PW,Barragan P,et al.Long-term clinical outcomes with sirolimus-eluting coronary stents:five-year results of the RAVEL trial.J Am Coll Cardiol,2007,50:1299-1304.
  • 4Lotan C,Meredith IT,Mauri L,et al.Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice:12-month data from the E-Five registry.JACC Cardiovasc Interv,2009,2:1227-1235.
  • 5Stone GW,Midei M,Newman W,et al.Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease:a randomized trial.JAMA,2008,299:1903-1913.
  • 6Kandzari DE,Leon MB,Popma JJ,et al.Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease:a randomized controlled trial.J Am Coll Cardiol,2006,48:2440-2447.
  • 7Eisenstein EL,Leon MB,Kandzari DE,et al.Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent:3-year results from the ENDEAVOR Ⅲ trial (randomized controlled trial of the Medtronic Endeavor drug[ABT-578] eluting coronary stent system versus the Cypher sirolimus-eluting coronary stent system in de novo native coronary artery lesions).JACC Cardiovasc Interv,2009,2:1199-1207.
  • 8Matsumoto D,Shite J,Shinke T,et al.Neointimal coverage of sirolimus-eluting stents at 6-month follow-up:evaluated by optical coherence tomography.Eur Heart J,2007,28:961-967.
  • 9Kim JS,Jang IK,Kim JS,et al.Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up:comparison with sirolimus-eluting stents.Heart,2009,95:1907-1912.
  • 10Rasmussen K,Maeng M,Kaltoft A,et al.Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT Ⅲ):a randomised controlledsuperiority trial.Lancet,2010,375:1090-1099.

共引文献10

同被引文献16

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部